Vanguard Group
NVOS

Vanguard Group’s Novo Integrated Sciences, Inc. Common Stock NVOS Stock Holding History

Vanguard Group’s Portfolio NVOS Stock Details NVOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-307,435
Closed -$86.4K – 4386
2024
Q3 		$86.4K Sell
307,435
-45,651
-13% -$21.3K ﹤0.01% 4206
2024
Q2 		$265K Buy
353,086
+103,454
+41% +$66.2K ﹤0.01% 4123
2024
Q1 		$122K Hold
249,632
– – ﹤0.01% 4223
2023
Q4 		$205K Buy
249,632
+114,694
+85% +$233K ﹤0.01% 4221
2023
Q3 		$402K Buy
134,938
+111,052
+465% +$203K ﹤0.01% 4112
2023
Q2 		$35.4K Buy
+23,886
New +$32.6K ﹤0.01% 4493
2023
Q1 		– Sell
-17,483
Closed -$35.2K – 4588
2022
Q4 		$35.2K Sell
17,483
-8,111
-32% -$27.9K ﹤0.01% 4467
2022
Q3 		$269K Hold
25,594
– – ﹤0.01% 4372
2022
Q2 		$479K Hold
25,594
– – ﹤0.01% 4305
2022
Q1 		$591K Hold
25,594
– – ﹤0.01% 4359
2021
Q4 		$358K Hold
25,594
– – ﹤0.01% 4486
2021
Q3 		$471K Hold
25,594
– – ﹤0.01% 4385
2021
Q2 		$642K Buy
+25,594
New +$638K ﹤0.01% 4229

Other funds holding NVOS

AA
ACT Advisors Asheville, North Carolina $301M AUM 23.36% 1-Year Est. Return

Vanguard Group's NVOS Position: Q4 2024 in Review

Vanguard Group sold out of Novo Integrated Sciences, Inc. Common Stock (NVOS) in Q4 2024, closing a stake of 307,435 shares — an estimated $86.4K sold.

Vanguard Group first reported a position in NVOS in Q2 2021 and held it in 13 quarters. The position peaked at $642K in Q2 2021. 1 fund tracked by Wall St. Rank holds NVOS as of Q4 2024.

  • Vanguard Group reported no remaining Novo Integrated Sciences, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
  • Vanguard Group sold 307,435 Novo Integrated Sciences, Inc. Common Stock shares in Q4 2024, an estimated $86.4K.
  • Vanguard Group first reported a position in Novo Integrated Sciences, Inc. Common Stock in Q2 2021 and held it in 13 quarters.
  • Vanguard Group's Novo Integrated Sciences, Inc. Common Stock position peaked at $642K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Novo Integrated Sciences, Inc. Common Stock as of Q4 2024.

Based on Vanguard Group's 13F filing for Q4 2024, filed 11 Feb 2025.